- Shanghai Nianxing Industrial Co., Ltd
- China
- Product Name: Ethyl imidazo[1,5-a]pyridine-8-carboxylate
- Price:
- Purity: 98.0%
- Stocking Period: 10 Day
- Contact: Yang
- Shanghai Jizhi Biochemical Technology Co., Ltd
- China
- Product Name: Ethyl imidazo[1,5-a]pyridine-8-carboxylate
- Price: ￥488.0/25mg ￥1168.0/100mg
- Purity: 98.0%
- Stocking Period: 2 Day
- Contact: Liu jia
- Dayang Chem (Hangzhou) Co., Ltd.
- China
- Product Name: ETHYL IMIDAZO[1,5-A]PYRIDINE-8-CARBOXYLATE
- Price: $Inquiry/100g $Inquiry/1kg $Inquiry/100kg $Inquiry/1000kg
- Purity: 98.0%
- Stocking Period: Inquiry
- Contact: Ms Wang
697739-12-1
697739-12-1 structure
- Name: Ethyl imidazo[1,5-a]pyridine-8-carboxylate
- Chemical Name: Ethyl imidazo[1,5-a]pyridine-8-carboxylate
- CAS Number: 697739-12-1
- Molecular Formula: C10H10N2O2
- Molecular Weight: 190.19900
- Create Date: 2018-12-03 15:55:23
- Modify Date: 2024-01-10 19:23:17
| Name | Ethyl imidazo[1,5-a]pyridine-8-carboxylate |
|---|---|
| Synonyms | ethyl imidazol[1,5-a]pyridine-8-carboxylate |
| Molecular Formula | C10H10N2O2 |
|---|---|
| Molecular Weight | 190.19900 |
| Exact Mass | 190.07400 |
| PSA | 43.60000 |
| LogP | 1.51100 |
| Hazard Codes | Xi |
|---|---|
| HS Code | 2933990090 |
|
~%
697739-12-1 |
| Literature: GLOBAL BLOOD THERAPEUTICS, INC.; CYTOKINETICS, INC.; THE REGENTS OF THE UNIVERSITY OF CALIFORNIA; METCALF, Brian; CHUANG, Chihyuan; WARRINGTON, Jeffrey; PAULVANNAN, Kumar; JACOBSON, Matthew P.; HUA, Lan; MORGAN, Bradley Patent: WO2013/102142 A1, 2013 ; Location in patent: Paragraph 0143 ; |
|
~57%
697739-12-1 |
| Literature: Merck Sharp and Dohme Limited Patent: WO2004/46133 A1, 2004 ; Location in patent: Page 32 ; WO 2004/046133 A1 |
|
~%
697739-12-1 |
| Literature: GLOBAL BLOOD THERAPEUTICS, INC.; CYTOKINETICS, INC.; THE REGENTS OF THE UNIVERSITY OF CALIFORNIA; METCALF, Brian; CHUANG, Chihyuan; WARRINGTON, Jeffrey; PAULVANNAN, Kumar; JACOBSON, Matthew P.; HUA, Lan; MORGAN, Bradley Patent: WO2013/102145 A1, 2013 ; Location in patent: Paragraph 0250 ; |
|
~%
697739-12-1 |
| Literature: GLOBAL BLOOD THERAPEUTICS, INC.; CYTOKINETICS, INC.; THE REGENTS OF THE UNIVERSITY OF CALIFORNIA; METCALF, Brian; CHUANG, Chihyuan; WARRINGTON, Jeffrey; PAULVANNAN, Kumar; JACOBSON, Matthew P.; HUA, Lan; MORGAN, Bradley Patent: WO2013/102142 A1, 2013 ; |
|
~%
697739-12-1 |
| Literature: GLOBAL BLOOD THERAPEUTICS, INC.; CYTOKINETICS, INC.; THE REGENTS OF THE UNIVERSITY OF CALIFORNIA; METCALF, Brian; CHUANG, Chihyuan; WARRINGTON, Jeffrey; PAULVANNAN, Kumar; JACOBSON, Matthew P.; HUA, Lan; MORGAN, Bradley Patent: WO2013/102142 A1, 2013 ; |
|
~%
697739-12-1 |
| Literature: GLOBAL BLOOD THERAPEUTICS, INC.; CYTOKINETICS, INC.; THE REGENTS OF THE UNIVERSITY OF CALIFORNIA; METCALF, Brian; CHUANG, Chihyuan; WARRINGTON, Jeffrey; PAULVANNAN, Kumar; JACOBSON, Matthew P.; HUA, Lan; MORGAN, Bradley Patent: WO2013/102142 A1, 2013 ; |
| Precursor 5 | |
|---|---|
| DownStream 1 | |
![Imidazo[1,5-a]pyridine-8-carboxylic acid structure](https://image.chemsrc.com/caspic/227/697739-13-2.png)
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |